Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 11, 2006

Immtech Finds Compounds to Potentially Tackle Drug Resistance

  • Immtech Pharmaceuticals scientists reported that in collaboration with its consortium partners they have identified a unique class of compounds with activity in treating antibiotic-susceptible and antibiotic-resistant Gram-positive bacterial pathogens, or the super bugs.

    "It is clear that there is an overwhelming need to develop new medicines because of growing resistance to current treatments,” says Norman Abood, Ph.D., vp, discovery programs. “We believe Immtech is uniquely positioned to advance new compounds from this class through optimization and preclinical phases in preparation for testing in the clinic, where a critical need exists for new novel agents".

    Immtech scientists screened its chemical library and identified a class of aromatic dications with potent activity against a panel of methicillin-sensitive Staph (Staphylococcus aureus), methicillin-resistant Staph, and vancomycin-resistant Enterococcus, according to the company. The team then performed a second round of testing on a more focused subclass of compounds to refine the structure-activity relationships for this new class.

    Immtech says it will now continue with lead optimization and advanced testing in in vivo models of efficacy. The market for anti-MRSA antibiotics is expected to reach $2 billion in 2006, according to a May 2006 Episcom Business Intelligence report.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »